Dec 06 Who wins and loses with the 21st Century Cures Act? By Sheila Kaplan, STAT More than 1,300 lobbyists roamed the halls of Congress on the 21st Century Cures Act, and disclosure reports show most of them were working for pharmaceutical companies. Continue reading
Jun 02 Column: Our zeal for antibiotics in agriculture could become an economic nightmare By Vikram Mansharamani The superbug is a reminder of the unintended consequences of the modern quest for productivity. Barring a solution, it will take an enormous toll. Continue reading
Feb 10 Lower drug prices: Does any candidate have an Rx? By Philip Moeller The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office. Continue reading
Feb 04 Watch 3:59 News Wrap: Embattled pharma CEO takes Fifth before Congress By PBS News Hour In our news wrap Thursday, embattled ex-Turing Pharmaceuticals CEO Martin Shkreli pleaded the Fifth when called to testify before Congress on drug pricing protocols. Also, 12.7 million Americans signed up for private health insurance under the Affordable Care Act this… Continue watching
Dec 25 Watch 6:18 How drug companies are gaming an old law for greater profits By PBS News Hour In the 1980s, a law was passed to persuade pharmaceutical companies to develop drugs for small populations, but now that rule is being used to reclaim old "orphaned" drugs in order to raise prices and profits. Gwen Ifill learns more… Continue watching
Sep 29 Watch 7:08 Is profit or innovation driving the rising costs of drugs? By PBS News Hour Turing Pharmaceuticals sparked outcry when it raised the price of a single pill from $13 to $750. Judy Woodruff discusses the rising costs of prescriptions drugs with Dr. Peter Bach of Memorial Sloan Kettering Cancer Center and Dr. Thomas Stossel… Continue watching
Sep 23 After controversy, pharmaceutical company will lower price of AIDS drug By Michelle Harven After outrage from the public and even presidential candidates, Turing Pharmaceuticals has announced it will reduce the price of the drug whose cost had previously increased by more than 5,000 percent practically overnight. Continue reading
Jun 10 Watch 7:03 Powerful new class of cholesterol drugs offers hope for some patients By PBS News Hour More than 30 million Americans take statins to lower their cholesterol, according to estimates. But these popular drugs don't work for everyone. Now the FDA may be poised to approve a powerful new class of drugs that can attack cholesterol… Continue watching
Apr 20 Drugmaker settles for $512 million in suit over delayed generics By Megan Thompson Pharmaceutical maker Teva has agreed to a settlement of $512 million in a class action lawsuit over the wakefulness drug Provigil. Drug wholesalers and retailers claimed a generic version of the drug was delayed to market by so-called “pay for… Continue reading
Jan 19 The wealthiest are getting wealthier, and lobbying has a lot to do with it By Simone Pathe On the eve of the president's State of the Union address and the World Economic Forum, Oxfam is predicting a widening wealth gap and pointing a finger at the millions of dollars spent on lobbying in the United States for… Continue reading